Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models

  1. Morteza Chalabi Hajkarim
  2. Ella Karjalainen
  3. Mikhail Osipovitch
  4. Konstantinos Dimopoulos
  5. Sandra L Gordon
  6. Francesca Ambri
  7. Kasper Dindler Rasmussen
  8. Kirsten Grønbæk
  9. Kristian Helin
  10. Krister Wennerberg  Is a corresponding author
  11. Kyoung-Jae Won  Is a corresponding author
  1. University of Copenhagen, Denmark
  2. University of Helsinki, Finland
  3. Rigshospitalet, Denmark
  4. University of Dundee, United Kingdom
  5. Memorial Sloan Kettering Cancer Center, United States

Abstract

Large-scale multiparameter screening has become increasingly feasible and straightforward to perform thanks to developments in technologies such as high-content microscopy and high-throughput flow cytometry. The automated toolkits for analyzing similarities and differences between large numbers of tested conditions have not kept pace with these technological developments. Thus, effective analysis of multiparameter screening datasets becomes a bottleneck and a limiting factor in unbiased interpretation of results. Here we introduce compaRe, a toolkit for large-scale multiparameter data analysis, which integrates quality control, data bias correction, and data visualization methods with a mass-aware gridding algorithm-based similarity analysis providing a much faster and more robust analyses than existing methods. Using mass and flow cytometry data from acute myeloid leukemia and myelodysplastic syndrome patients, we show that compaRe can reveal interpatient heterogeneity and recognizable phenotypic profiles. By applying compaRe to high-throughput flow cytometry drug response data in AML models, we robustly identified multiple types of both deep and subtle phenotypic response patterns, highlighting how this analysis could be used for therapeutic discoveries. In conclusion, compaRe is a toolkit that uniquely allows for automated, rapid, and precise comparisons of large-scale multiparameter datasets, including high-throughput screens.

Data availability

Mass cytometry datasets were downloaded from Cytobank Community with the experiment ID 44185. AML mouse and human high-throughput flow cytometry data have been deposited in FLOWRepository with the repository IDs FR-FCM-Z357 and FR-FCM-Z3DP respectively. Flow cytometry data of AML and MDS patients have been deposited in FLOWRepository with the repository ID FR-FCM-Z3ET. Acquisition, installation and more technical details are available in compaRe's online tutorial on (https://github.com/morchalabi/COMPARE-suite). Similarity measurement and clustering modules as stand-alone tools have been merged into a separate R package and are available for download at (https://github.com/morchalabi/compaRe).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Morteza Chalabi Hajkarim

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2039-2676
  2. Ella Karjalainen

    Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
    Competing interests
    The authors declare that no competing interests exist.
  3. Mikhail Osipovitch

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  4. Konstantinos Dimopoulos

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  5. Sandra L Gordon

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0270-8291
  6. Francesca Ambri

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Kasper Dindler Rasmussen

    School of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Kirsten Grønbæk

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  9. Kristian Helin

    Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Krister Wennerberg

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    For correspondence
    krister.wennerberg@bric.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1352-4220
  11. Kyoung-Jae Won

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    For correspondence
    kyoung.won@bric.ku.dk
    Competing interests
    The authors declare that no competing interests exist.

Funding

Novo Nordisk Foundation center for Stem Cell Biology (NNF17CC0027852)

  • Kirsten Grønbæk
  • Kristian Helin
  • Krister Wennerberg
  • Kyoung-Jae Won

Kræftens Bekæmpelse (R223‐A13071)

  • Kirsten Grønbæk
  • Kristian Helin
  • Krister Wennerberg
  • Kyoung-Jae Won

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Aleksandra M Walczak, CNRS LPENS, France

Ethics

Human subjects: The informed consent, and consent to publish of patient samples in this study has been approved by the Danish National Science Ethics Committee/National Videnskabsetisk Komite: Målrettet behandling af patienter med blodsygdomme, license no. 1705391.

Version history

  1. Preprint posted: January 9, 2021 (view preprint)
  2. Received: September 9, 2021
  3. Accepted: February 14, 2022
  4. Accepted Manuscript published: February 15, 2022 (version 1)
  5. Version of Record published: April 20, 2022 (version 2)
  6. Version of Record updated: May 3, 2022 (version 3)

Copyright

© 2022, Chalabi Hajkarim et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,269
    views
  • 211
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Morteza Chalabi Hajkarim
  2. Ella Karjalainen
  3. Mikhail Osipovitch
  4. Konstantinos Dimopoulos
  5. Sandra L Gordon
  6. Francesca Ambri
  7. Kasper Dindler Rasmussen
  8. Kirsten Grønbæk
  9. Kristian Helin
  10. Krister Wennerberg
  11. Kyoung-Jae Won
(2022)
Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models
eLife 11:e73760.
https://doi.org/10.7554/eLife.73760

Share this article

https://doi.org/10.7554/eLife.73760

Further reading

    1. Computational and Systems Biology
    Antony M Jose
    Research Article

    Interacting molecules create regulatory architectures that can persist despite turnover of molecules. Although epigenetic changes occur within the context of such architectures, there is limited understanding of how they can influence the heritability of changes. Here, I develop criteria for the heritability of regulatory architectures and use quantitative simulations of interacting regulators parsed as entities, their sensors, and the sensed properties to analyze how architectures influence heritable epigenetic changes. Information contained in regulatory architectures grows rapidly with the number of interacting molecules and its transmission requires positive feedback loops. While these architectures can recover after many epigenetic perturbations, some resulting changes can become permanently heritable. Architectures that are otherwise unstable can become heritable through periodic interactions with external regulators, which suggests that mortal somatic lineages with cells that reproducibly interact with the immortal germ lineage could make a wider variety of architectures heritable. Differential inhibition of the positive feedback loops that transmit regulatory architectures across generations can explain the gene-specific differences in heritable RNA silencing observed in the nematode Caenorhabditis elegans. More broadly, these results provide a foundation for analyzing the inheritance of epigenetic changes within the context of the regulatory architectures implemented using diverse molecules in different living systems.

    1. Computational and Systems Biology
    2. Ecology
    Kazushi Tsutsui, Ryoya Tanaka ... Keisuke Fujii
    Research Article

    Collaborative hunting, in which predators play different and complementary roles to capture prey, has been traditionally believed to be an advanced hunting strategy requiring large brains that involve high-level cognition. However, recent findings that collaborative hunting has also been documented in smaller-brained vertebrates have placed this previous belief under strain. Here, using computational multi-agent simulations based on deep reinforcement learning, we demonstrate that decisions underlying collaborative hunts do not necessarily rely on sophisticated cognitive processes. We found that apparently elaborate coordination can be achieved through a relatively simple decision process of mapping between states and actions related to distance-dependent internal representations formed by prior experience. Furthermore, we confirmed that this decision rule of predators is robust against unknown prey controlled by humans. Our computational ecological results emphasize that collaborative hunting can emerge in various intra- and inter-specific interactions in nature, and provide insights into the evolution of sociality.